Shuai Yuan

发表

Oxidative Stress Links Aging-Associated Cardiovascular Diseases and Prostatic Diseases

Cheng Fang, M. Zhao, Hao Zi, 2021, Oxidative medicine and cellular longevity.

Comprehensive Analysis of a Ferroptosis-related Gene Signature for Overall Survival and Immunotherapy Response in Patients With Bladder Urothelial Carcinoma

H. Weng, Xian-Tao Zeng, Tong Deng, 2021 .

Nanomaterials-Based Urinary Extracellular Vesicles Isolation and Detection for Non-invasive Auxiliary Diagnosis of Prostate Cancer

Ling Zhang, Cheng Fang, Xian-Tao Zeng, 2022, Frontiers in Medicine.

Oral microbiota in the oral-genitourinary axis: identifying periodontitis as a potential risk of genitourinary cancers

Xian-Tao Zeng, Cheng Fang, Bing-hui Li, 2021, Military Medical Research.

A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1

H. Weng, Dan-qi Wang, Lu-Yao Li, 2023, Cell Death & Disease.

Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019

H. Weng, Xian-Tao Zeng, Qiao Huang, 2021, Military Medical Research.

STAT1 is a key gene in a gene regulatory network related to immune phenotypes in bladder cancer: An integrative analysis of multi‐omics data

H. Weng, Xian-Tao Zeng, Qiao Huang, 2021, Journal of cellular and molecular medicine.

Aspartoacylase suppresses prostate cancer progression by blocking LYN activation

G. Wang, Jun Luo, Kaiyu Qian, 2023, Military Medical Research.

Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer

Yafei Li, Yi Cai, Yi-jie Zhang, 2023, Cell death & disease.

YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer

Shuai Yuan, Xian-Tao Zeng, Zhaojun Yu, 2023, Cell death and differentiation.